Reshoots. That single word can instill viewers with a sense of dread. That phrase, fairly or not, has come to indicate that a ...

Ahead of their return to directing in the MCU, The Russo Brothers' last entry in the MCU is finding streaming success on ...

The best shows on Netflix include The Night Agent, NCIS, The Walking Dead: The Ones Who Live, Castlevania: Nocturne, American ...

In a challenging market environment, Atossa Genetics Inc . (NASDAQ:ATOS) stock has touched a 52-week low, reaching a price ...

Eli Lilly's Ozempic-rivaling weight-loss pill orforglipron could be available in early 2026. Its retatrutide may be as ...

Weight loss treatments Mounjaro and Zepbound are the primary growth engines for Eli Lilly right now, but the company has another enormous opportunity that's getting very little attention.

While this is all great news for Verzenio, Lilly isn't stopping its ambitions in oncology care with just one treatment. Right now, the company has seven clinical trials underway exploring new ...

The Michael Almereyda and Courtney Stephens movie, narrated by Chloë Sevigny and premiering at the Rotterdam film festival, explores the life of the utopian neuroscientist who developed the isolation ...

Not long after reporting phase 2 data for one of its obesity candidates that appeared to put it on par with Eli Lilly’s Zepbound ... market launch with a new commercial leader.

Today's Research Daily features new research reports on 16 major stocks ... In this article, we are going to take a look at where Eli Lilly and Company (NYSE:LLY) stands against the other stocks ...

the board of directors of Eli Lilly and Company (NYSE: LLY) approved a new $15 billion share repurchase program. The company's prior $5 billion share repurchase program was completed in the fourth ...